Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 5/20 | 1.00 |
| ▸ | DHODH | Q02127 | 1/20 | 1.00 |
| ▸ | MAOB | P27338 | 3/20 | 0.81 |
| ▸ | MEN1 | O00255 | 2/20 | 0.81 |
| ▸ | LMNA | P02545 | 2/20 | 0.81 |
| ▸ | MAPT | P10636 | 2/20 | 0.81 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.81 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.81 |
| ▸ | GAA | P10253 | 1/20 | 0.81 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.72 |
| ▸ | TYR | P14679 | 2/20 | 0.72 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.72 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.72 |
| ▸ | CASP3 | P42574 | 1/20 | 0.67 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.67 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.67 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.67 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.61 |
| ▸ | TTR | P02766 | 1/20 | 0.61 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5518698 | 0.90 | PTPN1 (0.82) | PTPN1DHODHMAOBMEN1LMNA | |
| SCHEMBL5518692 | 0.90 | PTPN1 (0.82) | PTPN1DHODHMAOBMEN1LMNA | |
| Isocordoin SCHEMBL24075559 | 0.90 | PTPN1 (0.81) | PTPN1DHODHMAOBMEN1LMNA | |
| Xanthoangelol SCHEMBL454823 | 0.90 | MEN1 (1.00) | PTPN1DHODHMAOBMEN1LMNA | |
| Xanthoangelol SCHEMBL5519362 | 0.90 | MEN1 (1.00) | PTPN1DHODHMAOBMEN1LMNA | |
| Xanthoangelol SCHEMBL5519356 | 0.90 | MEN1 (1.00) | PTPN1DHODHMAOBMEN1LMNA | |
| SCHEMBL5515022 | 0.89 | MEN1 (0.98) | PTPN1DHODHMAOBMEN1LMNA | |
| SCHEMBL14523853 | 0.89 | MEN1 (0.98) | PTPN1DHODHMAOBMEN1LMNA | |
| SCHEMBL29696899 | 0.89 | PTPN1 (0.82) | PTPN1DHODHMAOBMEN1LMNA | |
| SCHEMBL21717734 | 0.89 | PTPN1 (0.80) | PTPN1DHODHMAOBMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 508 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4714440-A2 | A HEALING HERBAL-MINERAL COMPOSITION WITH ENHANCED EFFECTS | Kurek, Janusz (PL) | 2026-03-25 | — | — | EP | claimed |
| EP-4680720-A1 | OPTIMIZED PRODUCTION OF BRANCH POINT COMPOUNDS AND DERIVATIVES USING ALTERNATIVE ISOPENTENYL DIPHOSPHATE-SUPPLYING PATHWAYS | EvodiaBio ApS (DK) | 2026-01-21 | — | — | EP | claimed |
| US-12529077-B2 | Production of geranyl diphosphate-derived compounds | Københavns Universitet (DK) | 2026-01-20 | — | — | US | claimed |
| US-20250339399-A1 | SUPRAMOLECULAR SELF-ASSEMBLY SYSTEM | BEIJING CREATRON INSTITUTE OF PHARMACEUTICAL RES CO LTD (CN) | 2025-11-06 | — | — | US | claimed |
| EP-4543220-A2 | COMPOSITIONS FOR REDUCING METHANE EMISSIONS, ANIMAL FEEDS COMPRISING THEM AND THEIR USE TO REDUCE METHANE EMISSIONS | Mootral Innovations Limited (GB) | 2025-04-30 | — | — | EP | claimed |
| CN-119881186-A | Method for measuring content of multiple components in Jiaweiqing E pill | 北京同仁堂股份有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-119730731-A | Composition for reducing methane emissions, animal feed containing same and use thereof for reducing methane emissions | 莫特迩创新有限公司 | 2025-03-28 | — | — | CN | claimed |
| WO-2024189183-A1 | OPTIMIZED PRODUCTION OF BRANCH POINT COMPOUNDS AND DERIVATIVES USING ALTERNATIVE ISOPENTENYL DIPHOSPHATE-SUPPLYING PATHWAYS | EVODIABIO APS (DK) | 2024-09-19 | — | — | WO | claimed |
| CN-118660707-A | Supermolecule self-assembly system | 北京睿创康泰医药研究院有限公司 | 2024-09-17 | — | — | CN | claimed |
| US-20240266187-A1 | METHOD FOR ENHANCING STABILITY OF N-TYPE SEMICONDUCTOR THROUGH OXYGEN ELIMINATION | TIANJIN UNIVERSITY (CN) | 2024-08-08 | — | — | US | claimed |
| EP-2274411-A1 | XANTHOHUMOL COMPOSITIONS AND METHODS FOR TREATING SKIN DISEASES OR DISORDERS | BETAL LLC (US) | 2011-01-19 | — | — | EP | claimed |
| EP-2249641-A1 | NOVEL COMPOSITIONS CONTAINING XANTHOHUMOL-CYCLODEXTRIN COMPLEXES | Flaxan GmbH & Co. KG (US) | 2010-11-17 | — | — | EP | claimed |
| WO-2009126320-A1 | XANTHOHUMOL COMPOSITIONS AND METHODS FOR TREATING SKIN DISEASES OR DISORDERS | BETAL, LLC (US) | 2009-10-15 | — | — | WO | claimed |
| WO-2009108379-A1 | NOVEL COMPOSITIONS CONTAINING XANTHOHUMOL-CYCLODEXTRIN COMPLEXES | FLAXAN GMBH & CO. KG (US) | 2009-09-03 | — | — | WO | claimed |
| CN-101215229-A | Bavachalcone compounds capable of resisting plant epiphyte disease | SHENYANG INST OF CHEMICAL TECH (CN) | 2008-07-09 | — | — | CN | claimed |
| US-20070092551-A1 | Therapeutic agent | TAKARA BIO INC. (JP) | 2007-04-26 | — | — | US | claimed |
| EP-1623704-A1 | THERAPEUTIC AGENT | TAKARA BIO INC. (JP) | 2006-02-08 | — | — | EP | claimed |
| WO-2004022080-A2 | BUGUZHI AGENT AND COMPOSITION AND METHODS OF PREPARING AND ADMINISTERING THE SAME | THE UNIVERSITY OF HONG KONG (CN) | 2004-03-18 | — | — | WO | claimed |
| WO-2001001996-A9 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OSTEOPOROSIS | UNIV WESTERN AUSTRALIA (AU) | 2002-09-12 | — | — | WO | claimed |
| WO-2001001996-A1 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OSTEOPOROSIS | UNIVERSITY OF WESTERN AUSTRALIA (AU) | 2001-01-11 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12529077-B2 | Production of geranyl diphosphate-derived compounds | GGPS1, OGA, GBA3 | PTPN1 3536/4885DHODH 163/4885MAOB 1375/4885 |
| US-20250339399-A1 | SUPRAMOLECULAR SELF-ASSEMBLY SYSTEM | S100A8, TP53, AQP1 | PTPN1 2775/4885DHODH 1206/4885MAOB 4411/4885 |
| US-20070092551-A1 | Therapeutic agent | FABP4, GPR119, IAPP | PTPN1 1950/4885DHODH 3351/4885MAOB 4382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.